Texas • New listing

Specialty Pharmacy for Sale — Texas

American HealthCare Capital is pleased to introduce a highly profitable specialty pharmacy for sale in Texas. This well-established company has a long-standing presence and outstanding reputation within the local communities they serve. The specialty pharmacy focuses on Rheumatology, Dermatology, G.I. diseases, Hypercholesterolemia, Viral Hepatitis, and Osteoporosis. Although they have focused primarily on serving Texas thus far, they are licensed in a total of 31 states, which could be a source of major growth. The pharmacy accepts all major payers, including Medicare, Medicaid, and private insurance. They have been able to achieve rapid growth within the last few years, with gross revenues of around $22 million in 2017 and $31 million in 2018. They are projecting gross revenues of $36 million in 2019 with an adjusted EBITDA of $1.5 million (4.7%) and an average script count of 1,000 per month. There is a full complement of staff that is expected to stay on post-acquisition. The sellers would like to pursue other business ventures but will assist during a transitional period as needed. The asking price for this opportunity is $12 Million plus the cost of inventory.
Asking price
$12,000,000
Annual revenue
$31,000,000
Type
Specialty Pharmacy
Location
Texas
Listing verified
2026-09-03

Listing broker

This pharmacy is represented by American HealthCare Capital (PRIME exits). Full identity and financials come directly from the listing broker, typically after a confidentiality agreement.

View this listing on the broker's site

More pharmacies for sale in Texas

  • Long-Term Care Pharmacy with Compounding

    Texas

    New

    Offered Through Affiliate Partner Central Texas Pharmacy Retail Pharmacy for sale in central Texas. This pharmacy filled 64,853 prescriptions and generated $4,997,700 in sales in 2025. Owner runs this store on a semi-absentee basis and just oversees the operation but does not work pharmacist shifts at the store. This pharmacy has been a pillar of the community for over 60 years. Located in a modern freestanding 3,000 square foot building (owned by the proprietor) the pharmacy has a drive-thru window and provides both delivery and charge accounts with some long-term care services. The store had retail pharmacy gross profit of $737,535 with an average prescription price of $74.95 in 2025. The pharmacy currently does not compound prescriptions but has space available to build a compounding lab. The store also provides a nice assortment of OTC and gift merchandise. Insurance contracts are established and the licenses are in order with the Board of Pharmacy and DEA. This is great opportunity for both a semi-absentee owner or an owner operator who wants to own and operate the business. << Return to Listings Inquire on this Business Listing ID: ABMD-26055385-40 Location: Central Texas Typ

    Asking price
    930,000
    Annual revenue
    4,997,000

    Listed by Hayslip & Zost Pharmacy Brokers (Advanced Business Brokers)

  • Independent Pharmacy

    Texas

    New

    PRIME exits and American HealthCare Capital are pleased to exclusively introduce a retail pharmacy for sale in northwest Texas. The pharmacy has been in business over a decade. They are strategically located in a shopping center with other medical businesses.

    Asking price
    $2,600,000
    Annual revenue
    $15,000,000

    Listed by American HealthCare Capital (PRIME exits)

  • Long-Term Care Pharmacy with Compounding

    Texas

    New

    American HealthCare Capital is pleased to introduce a new Home Infusion Pharmacy for sale in Texas. The company is licensed by the Texas State Board of Pharmacy as a Community Pharmacy Compounding Sterile Preparations Class A-S Pharmacy. It is also considered a Closed Door, Specialty Pharmacy. Their license allows for the community dispensing of oral medications, as well as for patients to come into the pharmacy for Infusion Therapy Treatments, i.e. Infusion Suites. In the state of Texas, the pharmacy license can be transferred anywhere within the state. The home infusion pharmacy for sale is equipped with a Certified Clean Room with an ISO 8 AnteRoom, ISO 7 Buffer Room, and an ISO 5 Certified Laminar Flow Hood. Thus far, the pharmacy has not generated any revenue. They have recently received approval for accreditation/DMEPOS with ACHC to provide billing of enteral pumps and supplies, external infusion pumps and supplies, parenteral equipment and supplies, and parenteral nutrients. They have received their Medicare billing number and have the following statuses with Managed Care Contracts: out of network with BCBSTX, pending in-network contracts with BCBSTX, and letters of intent with Aetna and Humana. The owner and Pharmacist in Charge are available to assist during a transitional period. The asking price for this business for sale in Texas is $100,000.

    Asking price
    $100,000

    Listed by American HealthCare Capital (PRIME exits)

  • Mail-Order Pharmacy with Compounding

    Texas

    New

    American HealthCare Capital is pleased to introduce a retail pharmacy headquartered in Southeast Texas and Florida. The business generates approximately 99% of its revenue from dispensing diabetic supplies to patients nationwide. The business operates a traditional brick and mortar pharmacy in Texas and a marketing and order validation facility in Florida. The pharmacy has full licensure in most states. Operations could easily be expanded into other states by obtaining additional Pharmacy licenses, which would generate additional revenue. They accept all 3rd party insurance carriers and Part D Plans. Gross revenues are expected to reach $2 Million by the end of 2018 with the majority of the sales coming from high margin diabetic supplies. The Gross Margin is approximately 60% with net income of approximately 12%. This opportunity is an excellent launching point for an entity looking to quickly grow a specialty, retail, compounding , or a mail order pharmacy operation. It would also be an excellent add on to an existing Pharmacy and would greatly assist in increasing gross profit margins in most Pharmacy settings. The seller is motivated and would like to focus on other business ventures, but the rest of the staff, including the Pharmacist in Charge, will stay on with a new owner. The asking price for this opportunity is $1 Million.

    Asking price
    $1,000,000
    Annual revenue
    $2,000,000

    Listed by American HealthCare Capital (PRIME exits)

  • Long-Term Care Pharmacy

    Texas

    New

    American HealthCare Capital is pleased to introduce a Closed Door Specialty pharmacy for sale in the Dallas, Texas area. This well-established pharmacy focuses on Developmentally Disabled pediatric patients. They service patients throughout the state of Texas. The Pharmacy’s business is 100% Medicaid reimbursement. Payments are weekly with a DSO of no more than 9 days. Through August of 2017, the Pharmacy had gross revenues of $7,347,000 with a run rate of $11,000,000 through the end of the year. In 2016, gross revenue was $11,880,000. The drop in revenue began in May 2016 when Medicaid reduced its reimbursement, resulting in a decrease of approximately $80,000/month. Regardless, the Pharmacy net profit remains in the black, with an expected Adjusted EBITDA of $450,000 (4%) for 2017. Beyond Texas, there is a growing market for pharmacies focused on heavily disabled children. Ownership will assist through a transition period, and the CEO/Pharmacist in Charge is willing to stay on in an executive capacity. The asking price for this opportunity is $2.75 Million, plus the cost of inventory, which is estimated at $200,000.

    Asking price
    $2,750,000
    Annual revenue
    $11,000,000

    Listed by American HealthCare Capital (PRIME exits)

  • Long-Term Care Pharmacy

    Texas

    New

    American HealthCare Capital is pleased to introduce a Long Term Care Pharmacy for sale in Houston, Texas. The pharmacy has been in business since 2013 and they are licensed as a Community Independent Pharmacy. They focus on serving I/DD population care facilities. The company’s sole payer is Medicaid/Managed Medicaid. The company has contracts to service 118 beds in a number of group homes and foster homes in the surrounding area. The company is currently dispensing an average of 1,080 scripts per month. Gross revenues were over $1 million in 2018 with a Gross Profit Margin of 19%, and the company expects to see an increase in 2019. The seller would like to focus on other ventures but expects the core staff to stay on, including the Pharmacist in Charge and Pharmacy Technician. The asking price for this opportunity is $200,000 plus the cost of inventory.

    Asking price
    $200,000
    Annual revenue
    $1,000,000

    Listed by American HealthCare Capital (PRIME exits)